Introduction {#Sec1}
============

*trans*-Fatty acids are unsaturated fatty acids characterized by the *trans* configuration of their double bonds. The two main industrially produced *trans*-isomers,18:1*t*-and 18:2*t*-fatty acids are created by partial hydrogenation of unsaturated fats and have well documented adverse effects on health \[[@CR1], [@CR2]\]. The health effects of 16:1n-7*t*-fatty acids and 18:2n-7*t* fatty acids collectively known as conjugated linoleic acid (CLA) are less well understood.

The 9c, 11*t* isomer of CLA, also known as rumenic acid, is found in ruminant food products. These natural *trans*-fats originate mainly from biohydrogenation of linoleic acid by fermentive bacteria in ruminants and by endogenous synthesis from vaccenic acid by delta-9 desaturase \[[@CR3]\]. Rumenic acid, represents \~80% of all CLA isomers in the diet \[[@CR4]\], and is mainly found in dairy products in this population \[[@CR5]\].

In humans and monkeys, high 18:1*t* and 18:2*t*-fatty acid intake appears to predispose to accumulation of body fat, particularly abdominal fat \[[@CR6], [@CR7]\]. Among more than 16,000 men who provided two measurements of abdominal circumference at an interval of 9 years, each 2% increase in total energy from *trans*-fatty acids (versus the same percent of energy from *cis*-polyunsaturated fat) was associated with a 2.7-cm increase in abdominal circumference (*P* \< 0.001) after adjustment for measurement error and other risk factors \[[@CR7]\]. Among more than 41,000 women who provided two measurements of body weight at an interval of 8 years, increases in *trans*-fatty acid intake were robustly associated with increases in body weight in both cross-sectional and longitudinal analyses, whereas intakes of other types of fat were not \[[@CR8]\]. In a 6-year randomized controlled trial among 42 male African green monkeys feeding \~8% of energy 18:1*t*- and 18:2*t*-fatty acids resulted in a threefold greater weight gain compared with controls assigned to a diet containing *cis*-monounsaturated fatty acids (*P* \< 0.05) \[[@CR6]\]. However, evidence from human intervention studies has been inconclusive \[[@CR9], [@CR10]\].

The purpose of this study was to evaluate the associations between the most common *trans*-fatty acid isomers (18:1*t*, 18:2*t*, 16:1n-7*t* and rumenic acid) and adiposity in a population of Costa Rican adults. We used adipose tissue levels of *trans*-fatty acids as a marker for intake because the *trans*-fatty acid content of foods has changed considerably and subcutaneous adipose tissue is considered the best choice for the study of long-term fatty acid intake \[[@CR11], [@CR12]\].

Methods {#Sec2}
=======

Study Population {#Sec3}
----------------

Subjects were randomly selected population controls from a case--control study on diet and heart disease conducted in Costa Rica as previously described \[[@CR13]\]. Participation was 88%. We included a total of 1,334 men and 451 women. Subjects gave informed consent on documents approved by the Human Subjects Committee of the Harvard School of Public Health and the University of Costa Rica.

Data Collection {#Sec4}
---------------

Data were collected by trained personnel visiting the subjects at their homes. Subjects provided information on socioeconomic, demographic, diet, and medical history during an interview. Anthropometric measures collected were height, weight, waist circumference and skinfold thickness for subscapular, suprailiac and triceps. All anthropometric measurements were taken from subjects wearing light clothing and no shoes, and collected in duplicate and averaged out for analyses. Field workers measured triceps (posterior upper arm, midway between the elbow and acromion), subscapular (1 cm below the lower tip of the scapula), and suprailiac (at the midline and above the iliac crest) using Holtain skinfold calipers. All measurements were taken on the right side of the body. Nonstretching fiberglass or metal tapes were used to measure the waist (smallest horizontal trunk circumference) and hip (largest horizontal circumference around the hip and buttocks) girths. A steel anthropometer and a Detecto bathroom scale or a Seca Alpha Model 770 digital scale accurate to 50 g were used to measure height and weight, respectively. The two scales were calibrated biweekly. Body mass index (BMI) was then calculated as weight (kg) divided by the square of the height (m^2^). BMI categories were defined by general accepted cut-off points. Normal weight was determined as a BMI lower than 25 kg/m^2^, overweight as a BMI between 25 and 30 kg/m^2^ and obesity was defined as a BMI above 30 kg/m^2^.

A subcutaneous adipose tissue biopsy was collected from the upper buttock with a 16-gauge needle and disposable syringe following procedures previously described \[[@CR14]\]. Samples were stored in a cooler at 4 °C and transported to the fieldwork station where they were stored at −80 °C. Within 6 months, they were shipped on dry ice to the Harvard School of Public Health for long term storage in nitrogen tanks. Energy and nutrient intakes were assessed with a food frequency questionnaire developed and validated specifically for use among Costa Ricans \[[@CR14], [@CR15]\]. Dietary information obtained by the food frequency questionnaire was used for validation purposes and to assess confounding by dietary factors that do not have good biomarkers of intake. The fatty acid composition of all foods commonly used in Costa Rica was determined \[[@CR16]\] and incorporated into the nutrient calculation.

Fatty Acid Analysis {#Sec5}
-------------------

Fatty acids were extracted from adipose tissue and analyzed by gas--liquid chromatography (GLC) \[[@CR14]\]. The fatty acids in the adipose tissue biopsy were extracted using hexane/isopropanol (3:2) mixture and esterified with methanol and acetyl chloride. After esterification, the methanol and acetyl chloride were evaporated and the fatty acid methyl esters were dissolved in isooctane. The methyl esters were quantified by GLC using the following parameters: fused silica capillary *cis*/*trans*-column SP2560, 100 m × 250 mm internal diameters × 0.20 mm film (Supelco, Belefonte, PA); splitless injection port at 240 °C; hydrogen carrier gas at 1.3 ml/min, constant flow; Hewlett-Packard Model (now Agilent) GC 6890 FID gas chromatograph with 7673 Autosampler injector (Palo Alto, CA); 1 ml of sample injected; temperature program of 90--170 °C at 10 °C/min, 170 °C for 5 min, 170--175 °C at 5 °C/min, 175--185 °C at 2 °C/min, 185--190 °C at 1 °C/min, 190--210 at 5 °C/min, 210 °C for 5 min, 210--250 °C at 5 °C/min, 250 °C for 10 min. Peak retention time and area percentages of total fatty acids were identified by injecting known standards (catalog numbers 47791, GLC-463, GLC-481b, N-16-M, N-21-M, N-23-M, N-24-M, U-45-M, U-46-M, U-59-M, U-71-M and UC-60-M, Nu-Chek_prep, Elysium, MN), and analyzed with the Agilent Technologies ChemStation A.08.03 software (Agilent Technologies, Inc., Palo Alto, CA). Twelve identical samples were analyzed throughout the study. The inter-assay coefficients of variation for 18:1*t*, 18:2*t*, and 18:2n-7*t* (9*c*,11*t*) fatty acids were 15.7, 6.4, and 5.2%, respectively. We previously showed that the *trans*-fatty acid concentration in adipose tissue is a good biomarker of *trans*-fatty acid intake in the Costa Rican population \[[@CR14]\].

Statistical Analysis {#Sec6}
--------------------

Data are presented as means ± SD or *n* (%). The *trans*-fatty acids that we used in the analysis were defined as follows: 18:1*t* = 18:1*t* (n-7*t*) + 18:1*t* (n-9*t*) + 18:1*t* (n-11*t*); 18:2*t* = 18:2*t* (n-6*tt*) + 18:2*t* (n-6*ct*) + 18:2*t* (n-6*tc*). Data were analyzed with the SAS software v9.1 (SAS Institute, Cary, NC, USA) with the significance level set at *P* \< 0.05. Partial Spearman correlation coefficients were calculated, adjusted for age, sex, and area of residence for the association between adipose tissue fatty acids and several subject characteristics and potential confounders.

Multivariate regression was used to estimate the β coefficients and *P* values of the association between adipose tissue *trans*-fatty acid isomer content and indicators of adiposity. These calculations were adjusted for the matching factors age, sex and area of residence. To account for variation in lifestyle and dietary habits, further models adjusted for smoking status, physical activity and income, and self-reported history of diabetes and hypertension. In a third model we also adjusted for adipose tissue alpha-linolenic acid, which is present in partially hydrogenated soybean oil used for cooking and was the major dietary source of 18:2*t*-fatty acids in this population \[[@CR13]\].

Other potential confounders that were examined but not included in the final models were alcohol intake, fruit and vegetable intake, currently on weight loss diet, menopausal status, adipose tissue linoleic acid, arachidonic acid, long chain omega-3 fatty acids, and dietary patterns.

Results {#Sec7}
=======

The average BMI of all subjects was 26.4 kg/m^2^ (Table [1](#Tab1){ref-type="table"}). Subjects in the obese category were more likely to be female, have a higher income, a history of diabetes and hypertension and less likely to be physically active or smoke. Obese subjects had higher adipose levels of 18:2*t*-fatty acids and arachidonic acid, and lower levels of 18:1*t*-fatty acids, linoleic acid and alpha-linolenic acid.Table 1General characteristics of Costa Rican subjects by BMI categoryAll subjects\
(*n* = 1,785)Normal weight\
BMI \< 25 kg/m^2^\
(*n* = 688)Overweight\
25 \< BMI \< 30 kg/m^2^\
(*n* = 787)Obese\
BMI \> 30 kg/m^2^\
(*n* = 310)Age (years)58 ± 1158 ± 1258 ± 1157 ± 11Women (%)25202538Area of residence rural (%)34353435Monthly household income, (\$US/mo)583 ± 429548 ± 417597 ± 430631 ± 449Physical activity (METS/day)35.3 ± 15.036.9 ± 17.235.1 ± 13.732.3 ± 12.4Current smokers (%)^a^22301813History of diabetes (%)^b^14111421History of hypertension (%)^b^29183248Measures of adiposity BMI (kg/m^2^)26.4 ± 4.222.5 ± 1.927.2 ± 1.433.2 ± 3.0 Waist circumference (cm)91.0 ± 9.983.1 ± 6.793.1 ± 6.0103.2 ± 8.6 Triceps skin fold (mm)13.8 ± 6.711.0 ± 4.914.2 ± 6.118.8 ± 8.1 Subscapular skin fold (mm)16.8 ± 7.513.0 ± 4.617.9 ± 6.822.4 ± 9.7 Suprailiac skin fold (mm)12.5 ± 6.89.7 ± 5.113.2 ± 6.516.9 ± 8.0Adipose tissue fatty acids (% of total fatty acids)^c^ Total 18:1*t*^d^1.47 ± 0.531.57 ± 0.561.43 ± 0.521.35 ± 0.47 18:1 (n-12*t*)0.61 ± 0.250.64 ± 0.260.60 ± 0.250.57 ± 0.23 18:1 (n-9*t*)0.50 ± 0.200.53 ± 0.220.48 ± 0.190.46 ± 0.18 18:1 (n-7*t*)0.36 ± 0.180.39 ± 0.200.35 ± 0.180.32 ± 0.15 Total 18:2*t*1.15 ± 0.351.15 ± 0.381.15 ± 0.351.13 ± 0.31 18:2 (n-6*tt*)0.28 ± 0.100.28 ± 0.100.28 ± 0.100.28 ± 0.09 18:2 (n-6c*t*)0.56 ± 0.180.56 ± 0.190.56 ± 0.180.55 ± 0.16 18:2 (n-6*t*c)0.31 ± 0.100.31 ± 0.110.31 ± 0.100.30 ± 0.09 16:1 (n-7*t*)0.15 ± 0.060.14 ± 0.060.15 ± 0.060.15 ± 0.05Rumenic acid^f^0.56 ± 0.180.56 ± 0.180.56 ± 0.170.57 ± 0.17 18:2 (n-6)15.63 ± 3.8115.68 ± 3.9515.68 ± 3.8515.40 ± 3.34 20:4 (n-6)0.47 ± 0.140.41 ± 0.120.50 ± 0.140.54 ± 0.13 18:3 (n-3)0.65 ± 0.210.68 ± 0.220.65 ± 0.210.61 ± 0.19Dietary fatty acids (% fatty acids) Total 18:1*t*^d^2.4 ± 0.92.4 ± 1.02.4 ± 0.92.4 ± 0.9 Total 18:2*t*1.4 ± 1.01.4 ± 1.11.4 ± 1.01.4 ± 1.0 16:1 (n-7*t*)0.19 ± 0.080.19 ± 0.080.19 ± 0.080.19 ± 0.08Rumenic acid^f^0.32 ± 0.130.32 ± 0.140.32 ± 0.130.33 ± 0.14Values are means ± SD or n (%)*METS/day* metabolic equivalents for 24 h^a^Smoking ≥1 cigarette/day^b^Self-reported^c^As percent of total adipose fatty acids^d^18:1*t* is the sum of 18:1n-7*t*, 18:1n-9*t* and 18:1n-11*t*^e^18:2*t*-is the sum of 18:2n-6*tt,* 18:2n-6*ct* and 18:2n-6*tc*^f^Rumenic acid is the 9c, 11*t* isomer of 18:2 (n-7*t*) conjugated linoleic acid

The mean percentage plus standard deviation (SD) of *trans*-fatty acids in adipose tissue as percentage of total fatty acids was 2.7 ± 0.7 for total *trans*-fatty acids, 1.47 ± 0.53 for 18:1*t*, 1.15 ± 0.35 for 18:2*t,* 0.15 ± 0.06 for 16:1n-7*t* and 0.56 ± 0.18 for rumenic acid (Table [1](#Tab1){ref-type="table"}).

Adipose tissue *trans*-fatty acid content corresponded with their intake from the diet. The average *trans*-fatty acid intake as a percentage of total calories was 0.77 ± 0.30% for 18:1*t*, 0.07 ± 0.07% for 18:2*t*, 0.06 ± 0.03% for 16:1n-7*t* and 0.10 ± 0.05% for rumenic acid.

Adipose tissue 18:1*t*, 18:2*t* and rumenic acid, but not 16:1n-7*t* were inversely associated with physical activity (Table [2](#Tab2){ref-type="table"}). Within adipose tissue, the strongest correlation was between 18:1*t* and 18:2*t*-fatty acids (Spearman *r* = 0.51). Rumenic acid was weakly inversely associated with linoleic acid and alpha-linolenic acid (Spearman *r* = − 0.17 and −0.08, respectively) and weakly positively with arachidonic acid (Spearman *r* = 0.06) (data not shown).Table 2Correlations between adipose fatty acids and general characteristics of all subjectsAdipose tissue fatty acids:18:1*t*^c^18:2*t*^d^16:1n-7*t*Rumenic acid^e^General characteristics Monthly household income (\$US/mo)0.13\*\*\*0.11\*\*\*0.15\*\*\*0.06\*\* Physical activity (METS/day)−0.10\*\*\*−0.07\*\*0.06\*−0.10\*\*\* Current smokers (%)^a^−0.09\*\*−0.07\*\*−0.10\*\*\*0.06\*\* History of diabetes (%)^b^−0.04−0.05\*0.05\*−0.07\*\* History of hypertension (%)^b^0.06\*\*−0.0070.04−0.05\*Adipose tissue fatty acids (% total fatty acids) Total 18:1*t*^c^--0.51\*\*\*0.06\*\*0.32\*\*\* Total 18:2*t*^d^0.51\*\*\*--0.0030.37\*\*\* 16:1n-7*t*0.06\*\*0.003--0.11\*\*\* Rumenic acid^e^0.32\*\*\*0.37\*\*\*0.11\*\*\*-- 18:2 (n-6)0.08\*\*0.45\*\*\*0.15\*\*\*−0.17\*\*\* 20:4 (n-6)−0.34\*\*\*−0.040.07\*\*0.06\* 18:3 (n-3)0.05\*0.46\*\*\*0.14\*\*\*−0.08\*\*Dietary fatty acids (% total fatty acids) Total 18:1*t*0.28\*\*\*0.39\*\*\*−0.0030.25\*\*\* Total 18:2*t*0.19\*\*\*0.52\*\*\*−0.08\*\*\*0.05 16:1n-7t0.05\*−0.030.28\*\*\*0.21\*\*\*Rumenic acid^e^0.06\*\*−0.030.31\*\*\*0.23\*\*\*Partial Spearman correlation coefficients between adipose tissue *trans*-fatty acids (% of total fatty acids) and several variables (adjusted for age, sex and area of residence)*METS/day* metabolic equivalents for 24 h\* *P* \< 0.05; \*\* *P* \< 0.01; \*\*\* *P* \< 0.0001, *n* = 1,785^a^Smoking ≥ 1 cigarette/day^b^Self-reported^c^18:1*t* is the sum of 18:1n-7*t*-, 18:1n-9*t*-, and 18:1n-11*t*-adipose tissue fatty acids^d^18:2*t* is the sum of 18:2n-6*tt-,* 18:2n-6*ct*-, and 18:2n-6*tc*-adipose tissue fatty acids^e^Rumenic acid is the 9*c*,11*t*-isomer of 18:2 (n-7*t*) conjugated linoleic acid

Results of the multivariate regression models for associations were reported as one SD unit increase in adipose tissue *trans*-fatty acids and measures of adiposity (Table [3](#Tab3){ref-type="table"}). Increased adipose tissue 16:1n-7*t*- and 18:2*t*-fatty acids were associated with higher BMI and waist circumference, and 18:1*t*-fatty acids were associated with lower BMI and waist circumference. In contrast, 16:1n-7*t*-fatty acids were inversely associated with individual skinfold thicknesses, while rumenic acid was positively associated with each skinfold thickness. Adipose tissue 18:1*t*-fatty acids were not significantly associated with skinfold thickness. Rumenic acid was not significantly associated with BMI or waist circumference, but was positively related to skinfold thicknesses. In additional analyses, alpha-linolenic acid was inversely associated with BMI (model 3, beta −4.2, *p* \< 0.0001) and waist circumference (model 3, beta −10.0, *p* \< 0.0001).Table 3Multivariate regression coefficients for the association between adipose tissue *trans*-fatty acids (shown as one standard deviation change) and measures of adiposityAdipose tissue *trans*-fatty acids18:1*t*^a^18:2*t*^b^16:1n-7*t*Rumenic acid^c^BMI (kg/m^2^) Model 1−0.91 ± 0.12\*\*\*0.20 ± 0.120.35 ± 0.10\*\*0.20 ± 0.11 Model 2−0.92 ± 0.11\*\*\*0.12 ± 0.120.22 ± 0.10\*0.28 ± 0.11\*\* Model 3−1.13 ± 0.11\*\*\*0.69 ± 0.13\*\*\*0.37 ± 0.10\*\*0.03 ± 0.11Waist circumference (cm) Model 1−2.39 ± 0.27\*\*\*0.58 ± 0.28\*0.87 ± 0.23\*\*0.75 ± 0.25\*\* Model 2−2.39 ± 0.26\*\*\*0.43 ± 0.270.60 ± 0.22\*\*0.92 ± 0.24\*\* Model 3−2.88 ± 0.26\*\*\*1.78 ± 0.31\*\*\*0.95 ± 0.22\*\*\*0.34 ± 0.25Subscapular skinfold (mm) Model 1−0.20 ± 0.190.15 ± 0.20−2.42 ± 0.17\*\*\*1.79 ± 0.18\*\*\* Model 2−0.23 ± 0.190.05 ± 0.19−2.61 ± 0.16\*\*\*1.91 ± 0.18\*\*\* Model 3−0.69 ± 0.18\*\*1.33 ± 0.22\*\*\*−2.27 ± 0.16\*\*\*1.36 ± 0.18\*\*\*Triceps skinfold (mm) Model 10.08 ± 0.150.11 ± 0.16−1.51 ± 0.13\*\*\*1.30 ± 0.15\*\*\* Model 20.05 ± 0.150.05 ± 0.16−1.61 ± 0.13\*\*\*1.35 ± 0.14\*\*\* Model 3−0.27 ± 0.150.93 ± 0.18\*\*\*−1.38 ± 0.13\*\*\*0.97 ± 0.15\*\*\*Suprailiac skinfold (mm) Model 1−0.23 ± 0.16−0.07 ± 0.17−1.78 ± 0.14\*\*\*1.35 ± 0.15\*\*\* Model 2−0.25 ± 0.16−0.14 ± 0.17−1.89 ± 0.14\*\*\*1.41 ± 0.15\*\*\* Model 3−0.55 ± 0.16\*\*0.70 ± 0.19\*\*−1.67 ± 0.14\*\*\*1.06 ± 0.16\*\*\*Associations are β coefficients for 1 standard deviation (SD) difference in percentage of *trans*-fatty acids ± standard error, SD 16:1n-7*t* = 0.06, SD 18:1*t* = 0.53, SD 18:2*t* = 0.35, SD rumenic acid = 0.18Model 1: Includes all *trans*-fatty acid variables plus age, sex and area of residenceModel 2: Model 1 plus smoking status, physical activity, income, self reported history of diabetes and hypertensionModel 3: Model 2 plus energy intake and adipose tissue 18:3n-3 (alpha-linolenic acid)\* *P* \< 0.05; \*\* *P* \< 0.01; \*\*\* *P* \< 0.0001, *n* = 1,785^a^18:1*t* is the sum of 18:1n-7*t*-, 18:1n-9*t*-, and 18:1n-11*t*-adipose tissue fatty acids^b^18:2*t* is the sum of 18:2n-6*tt*-, 18:2n-6*ct*-, and 18:2n-6*tc*-adipose tissue fatty acids^c^Rumenic acid is the 9*c*,11*t*-isomer of 18:2 (n-7*t*)-conjugated linoleic acid

Discussion {#Sec8}
==========

This cross-sectional study in the Costa Rican population evaluated the association between adipose tissue *trans*-fatty acid isomers and adiposity. We included both industrially produced (18:1*t* and 18:2*t*) and naturally occurring (16:1n-7*t* and 18:2n-7, 9*c*, 11*t*) *trans*-fatty acids. The most striking result was the apparent heterogeneity in the associations between the different *trans*-fatty acid isomers in adipose tissue and measures of adiposity.

Among the specific *trans*-fatty acids, the most consistent finding was that the industrial 18:2*t*-fatty acids, coming from partially hydrogenated oils used for cooking, were associated with increased visceral and subcutaneous adiposity.

In addition to positive associations with adiposity, 18:2 *trans*-fatty acids have been found to be more adversely related to risk of cardiovascular disease (CVD) than are 18:1 *trans*-fatty acids \[[@CR17]--[@CR19]\]. A possible explanation for these adverse effects on CVD is that 18:2*t*-fatty acids are incorporated in the *sn*-2 position of phospholipids, where polyunsaturated fatty acids are usually found. This substitution might affect membrane properties and have effects on atherosclerotic pathways through increased macrophage adhesion \[[@CR20]\].

16:1n-7*t*-fatty acids, from ruminant food sources, have not been widely investigated. In this study 16:1n-7*t*-fatty acids were positively associated with BMI and waist circumference, and inversely with skinfold thickness. This suggests that 16:1n-7*t*-may be associated with increased visceral, rather than subcutaneous fat storage. These findings are in contrast with rumenic acid, also from ruminant food sources, which is associated with increased subcutaneous adiposity. Although differences in fatty acid metabolism between visceral and subcutaneous fat depots have been found \[[@CR21]\], we cannot explain the different associations of these natural *trans*-fatty acids with visceral and subcutaneous adiposity.

The finding of an inverse association between adipose tissue 18:1*t*-fatty acids and BMI is unexpected, given the positive associations found in other studies where 18:1*t*-fatty acids were the main *trans*-fatty acids in the diet \[[@CR6], [@CR8]\]. However, although the distribution of fat in monkeys fed a *trans*-fat diet favored an intra-abdominal distribution, the increases in body weight, weight circumference, subcutaneous and intra-abdominal fat were not significant, which is in line with our study \[[@CR6]\]. We cannot exclude that this redistribution of fat also happened in our subjects. Also, Koh-Banerjee et al. \[[@CR7]\] reported an increase in waist gain with higher *trans*-fat intake, but they did not validate the intake of *trans*-fatty acids in their food frequency questionnaire, which could introduce considerable bias since *trans*-fat content of foods has changed over time. In addition, short term studies conducted in small animals fed 18:1*t*-fatty acids as their main source of *trans*-fatty acids support our findings. These randomized controlled trials with rabbits and mice showed decreases in body weight, and perirenal and epididymal weight when fed diets high in 18:1*t*-fatty acids \[[@CR22], [@CR23]\]. The discrepancy between the observations in this study and those in other studies on industrial *trans*-fatty acids and weight might also be explained by the relatively low consumption of 18:1*t*-fatty acids in Costa Rica.

Adipose tissue rumenic acid was not significantly associated with BMI or waist circumference but did relate positively to skinfold thickness. Studies in rodents show associations between CLA and decreases in body fat \[[@CR24]\], but in humans the effects of CLA consumption on body weight are inconsistent \[[@CR9], [@CR10]\], which is in line with our findings.

Adiposity is primarily caused by an imbalance in energy consumption, leading to deposition of excess calories. However, Flint et al. \[[@CR25]\] showed that *trans*-fatty acid consumption had no effect on either appetite or energy expenditure. Food sources of 18:1*t*-fatty acids are mostly processed baked goods, while the main source of 18:2*t*-fatty acids in our population is cooking oil. However, this does not logically explain why 18:1*t*-fatty acids are associated with decreased adiposity, and 18:2*t*-fatty acids with increased adiposity. A clear mechanism for the observed associations cannot be given. Also, biochemical mechanisms to explain these observations such as interference with essential fatty acid desaturation and elongation \[[@CR26]\], insulin sensitivity \[[@CR27]\] and fat cell size \[[@CR28]\] does not explain the inverse associations we see with 18:1*t*-fatty acids and adiposity.

Together with the studies on *trans*-fatty acid isomers and CVD risk, the results from this study suggest that different associations exist between the individual *trans*-fatty acid isomers and health outcomes. Currently there is a trend among the food industry to reduce *trans*-fatty acids in common foods, which then might be replaced with oils that are less hydrogenated and contain relatively more 18:2*t*-fatty acids. Although the primary goal is to improve public health, this might have more adverse effects because of the adverse associations of 18:2*t*-fatty acids with CVD and adiposity. While a causal effect cannot be determined in this study, extrapolation of our findings suggests that eliminating all industrial 18:2*t*-fatty acids would be associated with a 7.1-cm decrease in waist circumference.

The use of adipose tissue *trans*-fatty acids is both a strength and a limitation of the study. Adipose tissue levels are not dependent on imperfect measures of dietary intake or food composition tables to determine the amount of *trans*-fatty acids in foods, which can pose a problem in dietary analyses since the *trans*-fatty acid content of foods can vary considerably over time. However, the concentration of fatty acids in adipose tissue not only reflects intake, but also metabolism and substitutions between fatty acids.

Reverse causation may influence the associations found in this study; increases in body weight are readily noticed by participants, which can lead to changes in energy intake and the choice of foods or to increased physical activity. Also, residual confounding is possible because of imperfect measurements of physical activity, dietary factors, and health consciousness.

In summary, our study provides evidence that individual *trans*-fatty isomers have divergent effects on adiposity. The main finding is the consistent adverse association between industrial 18:2*t* and all measures of adiposity. Also, 16:1n-7*t* and rumenic acid, both *trans*-isomers mainly found in dairy foods, have divergent effects which has not been reported previously. These isomer-specific associations pose new questions on how *trans*-fatty acids influence metabolism and weight. Other prospective and intervention studies are necessary to examine this further. Regardless of an association with adiposity, elimination of partially hydrogenated oils from the diet is important in efforts to reduce the burden of cardiovascular disease.

None.
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